Acquired expansion EyeJust was acquired by Ocushield in March 2024, signaling potential cross-sell opportunities with Ocushield’s blue light and eye health products and an expanded US presence.

US market focus With operations based in New York and recent acquisition activity boosting the US footprint, there is a clear opportunity to accelerate direct-to-consumer partnerships, retail placements, and B2B distribution in the United States.

Product extension EyeJust specializes in blue light blocking screen protectors; combined with Ocushield’s glasses lineup, there is a potential for bundled kits or multi-product offerings across devices and eyewear to capture broader customer segments.

SMB readiness The company operates with a lean team (2-10 employees) and targets health-conscious consumers; this suggests scalable, low-touch digital marketing playbooks, affiliate programs, and influencer partnerships that can rapidly scale sales.

Clinical credibility Endorsements from ophthalmology and dermatology professionals position EyeJust as a clinically informed brand, enabling sales approaches to clinics, wellness centers, and eye care practices for recommendations or white-label opportunities.